Search results
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 4 days agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new...
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
CNBC· 13 hours agoThe Food and Drug Administration on Friday expanded the approval of GSK's respiratory syncytial...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
KEYT 3 Santa Barbara· 3 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 4 days agoCancer vaccines are finally showing promise as Moderna and Merck touted promising data on an...
FDA vaccine advisers vote unanimously in favor of updated COVID-19 shot for fall
WPTZ Burlington· 2 days agoThe Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday to...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation...
KION 46 Salinas· 13 hours agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
Cow burps are a major source of methane emissions. A Boston startup is working on a vaccine to fix...
The Boston Globe· 22 hours agoCarbon dioxide may get more attention, but methane is more potent, with 84 times the warming power...
The FDA tells COVID-19 vaccine makers to update shot to target newest variant
KSL TV Utah· 10 hours agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
US FDA expands GSK’s RSV vaccine approval to adults aged 50 to 59
WSAU Wausau· 13 hours agoBy Sriparna Roy and Christy Santhosh (Reuters) -The U.S. Food and Drug Administration approved the...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 18 hours agoNovavax stock rocketed to a nearly two-year high in June, thanks to a $1.3 billion deal and the...